Finance

Beta
Roʻyxatlar
Aksiyalar sektorlari
Belgilar
Belgilar
Narxi
Oʻzgartirishlar
Dinamika (%)
Trend
Avvalgi yopilish narxi
Ochish
Yuqori
Past
Hajmi
Bozor kapitali
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
Q1 2026 daromadi • nashr etilgan • Aksiya boʻyicha daromad kutilganidan yuqori +8,04% • Daromad kutilganidan yuqori +0,55%
Natijalarini ochish
AMG:ETR
Amgen
296,80 €
+2,65%
(+7,65) 1K
30-apr, 17:35:37 (GMT+2)  ·   EUR
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
AMG tikeri uchun statistika yaratilmoqda...
Ochish
287,50 €
Yuqori
296,80 €
Past
286,90 €
Bozor kapitali
178,00 mlrd
Oʻrtacha hajm
309,00
Hajmi
346,00
52 haftalik eng yuqori
333,00 €
52 haftalik eng past
230,00 €
Xodimlar soni
32 ming
Yangiliklar
Internetdagi manbalardan
Profil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics. The company's major products are Prolia and XGEVA for treatment of osteoporosis and bone diseases, Enbrel for treatment of autoimmune diseases, Repatha for treatment of hyperlipidemia, Otezla for treatment of psoriasis and psoriatic arthritis, Tepezza to treat Graves' ophthalmopathy, Evenity to treat osteoporosis, Kyprolis to treat cancer, Nplate to regulate platelet production, and Aranesp to stimulate erythropoiesis. Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection. The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. The company is ranked 134th on the Fortune 500 and 202nd on the Forbes Global 2000. Wikipedia
Amgen haqida
CEORobert A. Bradway
Xodimlar soni31,5 ming
Asos solingan8-apr, 1980
Bosh ofislarTauzand-Oks, Kaliforniya, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytamgen.com
Oxirgi hisobot
30-apr, 2026
Moliya davri
Ch.1 2026
Normallashtirilgan EPS / Taxminiy
5,15/ (4,77 taxm.)USD
+8,04%musbat
Daromad / Taxminan
8,62 mlrd/ (8,57 mlrd taxm.)USD
+0,55%musbat
Q1 2026 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
QisqachaOxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad hisoboti
Daromad
Sof foyda
Barcha qiymatlar – USD
iyn, 2025
sen, 2025
dek, 2025
mar, 2026
Daromad
9,18 mlrd
9,56 mlrd
9,87 mlrd
8,62 mlrd
Sotilgan mahsulotning tannarxi
2,67 mlrd
2,74 mlrd
2,68 mlrd
2,74 mlrd
Daromad narxi
2,67 mlrd
2,74 mlrd
2,68 mlrd
2,74 mlrd
Tadqiqot va ishlanmalarga xarajatlar
1,74 mlrd
1,90 mlrd
2,14 mlrd
1,72 mlrd
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
1,69 mlrd
1,72 mlrd
1,95 mlrd
1,60 mlrd
Operatsion xarajatlar
3,50 mlrd
3,55 mlrd
4,18 mlrd
3,21 mlrd
Jami operatsion xarajatlar
6,18 mlrd
6,29 mlrd
6,85 mlrd
5,95 mlrd
Operatsion daromad
3,00 mlrd
3,26 mlrd
3,01 mlrd
2,67 mlrd
Boshqa nooperatsion daromad
-113,00 mln
181,00 mln
143,00 mln
75,00 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
1,57 mlrd
3,92 mlrd
1,51 mlrd
2,08 mlrd
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
2,37 mlrd
2,72 mlrd
2,51 mlrd
2,08 mlrd
Daromad soligʻi boʻyicha xarajat
136,00 mln
705,00 mln
181,00 mln
265,00 mln
Amaldagi soliq stavkasi
8,67%
17,98%
11,96%
12,72%
Boshqa operatsion xarajatlar
68,00 mln
-71,00 mln
82,00 mln
-113,00 mln
Sof foyda
1,43 mlrd
3,22 mlrd
1,33 mlrd
1,82 mlrd
Sof foyda marjasi
15,60%
33,65%
13,51%
21,11%
Har bir aksiya foydasi
6,02
5,64
5,29
5,15
Foizlar va investitsiyalardan olingan daromadlar
-
-
408,00 mln
-
Foizlarni toʻlash xarajatlari
-694,00 mln
-685,00 mln
-1,06 mlrd
-657,00 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
-694,00 mln
-685,00 mln
-653,00 mln
-657,00 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
4,34 mlrd
4,57 mlrd
4,02 mlrd
3,93 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish

Tahlil

Vazifalarim
Hali vazifa yaratmagansiz
Vazifalaringiz shu yerda chiqadi. Vazifalarni rejalashtiring va Google Finance xizmatidan foydalaning.
Andozalar
Kuzatuv roʻyxati brifingi
Kuzatuv roʻyxatining kunlik bozor oldidan tahlili
Kelgusi tushumlar
Hafta ichida kelgusi tushum hisobotlari
Anomal volatillik va hajm
Bugun erta ogohlantirish: volatillik va hajm
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish